Suraj Kalia Analyst PerformanceAnalyst at OppenheimerSuraj Kalia is a stock analyst at Oppenheimer in the medical sector, covering 19 publicly traded companies. Over the past year, Suraj Kalia has issued 18 stock ratings, including buy and hold recommendations. While full access to Suraj Kalia's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Suraj Kalia's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings67 Last 11 YearsBuy Recommendations69.23% 45 Buy RatingsCompanies Covered19 Unique Companies Ratings Distribution65RatingsDistribution of strong buy, buy, hold, and sell ratings by Suraj Kalia.RatingPercentageCount Strong Buy0.0%0 ratings Buy69.2%45 ratings Hold18.5%12 ratings Sell12.3%8 ratingsOut of 65 total stock ratings issued by Suraj Kalia at Oppenheimer, the majority (69.2%) have been Buy recommendations, followed by 18.5% Hold and 12.3% Sell.Best & Worst CallsBest Call0000.0%TMDXApr 2020Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%TCMDNov 2021Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ63.2% of companies on NASDAQ12 companiesNYSE36.8% of companies on NYSE7 companiesSuraj Kalia, an analyst at Oppenheimer, currently covers 19 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical19 companies100.0%Suraj Kalia of Oppenheimer specializes in stock coverage within the Medical sector.Coverage IndustriesIndustryPercentageMED PRODUCTS7 companies36.8%MED INSTRUMENTS7 companies36.8%MED - BIOMED/GENE3 companies15.8%MEDICAL INFO SYS1 company5.3%SURGICAL & MEDICAL INSTRUMENTS1 company5.3% Suraj Kalia's Ratings History at Oppenheimer Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsABTAbbott Laboratories4/17/2026Lower Price Target$95.08$115.00Outperform$0.0000.00% ROIPRCTPROCEPT BioRobotics2/26/2026Reiterated Rating$27.84Market Perform$0.0000.00% ROITMDXTransMedics Group2/25/2026Boost Price Target$133.26$175.00Outperform$0.0000.00% ROIPLSEPulse Biosciences2/20/2026Reiterated Rating$23.47$30.00Outperform$0.0000.00% ROIATRCAtriCure2/18/2026Downgrade$32.97Market Perform$0.0000.00% ROIABTAbbott Laboratories1/23/2026Lower Price Target$108.50$132.00Outperform$0.0000.00% ROIINSPInspire Medical Systems1/22/2026Downgrade$88.11Market Perform$0.0000.00% ROIBSXBoston Scientific1/16/2026Lower Price Target$90.00$100.00Outperform$0.0000.00% ROIINSPInspire Medical Systems12/19/2025Reiterated Rating$94.86Outperform$0.0000.00% ROIINSPInspire Medical Systems12/8/2025Upgrade$136.75$175.00Outperform$0.0000.00% ROIVREXVarex Imaging11/19/2025Lower Price Target$10.25$18.00Outperform$0.0000.00% ROIAORTArtivion11/7/2025Reiterated Rating$47.54$50.00Outperform$0.0000.00% ROIEWEdwards Lifesciences10/8/2025Downgrade$76.70Market Perform$0.0000.00% ROIPRCTPROCEPT BioRobotics9/2/2025Upgrade$40.17$60.00Outperform$0.0000.00% ROIPRCTPROCEPT BioRobotics7/7/2025Initiated Coverage$59.00Market Perform$0.0000.00% ROIPLSEPulse Biosciences7/7/2025Initiated Coverage$14.80$22.00Outperform$0.0000.00% ROITMDXTransMedics Group6/17/2025Boost Price Target$141.06$150.00Outperform$0.0000.00% ROITMDXTransMedics Group5/9/2025Boost Price Target$114.47$130.00Outperform$0.0000.00% ROIATRCAtriCure2/13/2025Boost Price Target$38.82$45.00Outperform$00.0000.00% ROIVREXVarex Imaging2/7/2025Lower Price Target$12.12$23.00Outperform$00.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageThe Goldman Sachs GroupBTIG ResearchDA DavidsonRoth MkmWall Street ZenUBS GroupCitigroupBarclaysWells Fargo & CompanyMorgan StanleyRoyal Bank Of CanadaJPMorgan Chase & Co.Jefferies Financial GroupTD CowenTruist Financial Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
